Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Topiramate NDC 45865-963 by Medsource Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 963

pdp - 963

This is a medication label for Topiramate tablets, which are the generic version of Topamax. The tablets are 50mg, and the recommended dosage is to take the tablets a certain number of times daily.*

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 01

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 01

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 02

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 02

The text describes a figure presenting the cumulative rates for time to the first seizure. The data is divided into two groups, one treated with Topiramate 50 mg/day and the other with Topiramate 400 mg/day. The graph used for the display is a Kaplan-Meier estimate. The x-axis represents time in days and ranges from 0 to 40.*

Topiramate Tablets USP - a9eed983 edf1 4f44 a8ec 568a52f03015 03

Topiramate Tablets USP - a9eed983 edf1 4f44 a8ec 568a52f03015 03

The text shows a table that presents the change from baseline to double-blind phase in average monthly migraine period rate for different dosages of topiramate and placebo. There are also values for the standard error and the number of participants in each group. The asterisks indicate statistical significance.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.